Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study. (Pubmed Abstract) Authors Lu CY, Law MR, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS Abbreviation Clin Ther Volume 33 Issue 1 Publication Date 2011-01-01
Towards integrated care: Australia's new model of care for patients with glaucoma. (Pubmed Abstract) Authors Lu CY, Lu VH, Goldberg I, Day RO Abbreviation Med. J. Aust. Volume 193 Issue 4 Publication Date 2010-09-16
Use of glaucoma medications: state of the science and directions for observational research. (Pubmed Abstract) Authors Lu VH, Goldberg I, Lu CY Abbreviation Am. J. Ophthalmol. Volume 150 Issue 4 Publication Date 2010-08-03
Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. (Pubmed Abstract) Authors Lu CY, Barratt J, Vitry A, Roughead E Abbreviation J Clin Epidemiol Volume 64 Issue 2 Publication Date 2010-06-18
Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. (Pubmed Abstract) Authors Law MR, Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS Abbreviation Clin Ther Volume 32 Issue 4 Publication Date 2010-04-01
Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness. (Pubmed Abstract) Authors Lu CY, Soumerai SB, Ross-Degnan D, Zhang F, Adams AS Abbreviation Med Care Volume 48 Issue 1 Publication Date 2010-01-01
Observational studies: a review of study designs, challenges and strategies to reduce confounding. (Pubmed Abstract) Authors Lu CY Abbreviation Int. J. Clin. Pract. Volume 63 Issue 5 Publication Date 2009-04-03
Pharmacoepidemiologic research in Australia: challenges and opportunities for monitoring patients with rheumatic diseases. (Pubmed Abstract) Authors Lu CY Abbreviation Clin. Rheumatol. Volume 28 Issue 4 Publication Date 2009-02-04
Utilization of allopurinol in the Australian community. (Pubmed Abstract) Authors Chung Y, Lu CY, Graham GG, Mant A, Day RO Abbreviation Intern Med J Volume 38 Issue 6 Publication Date 2008-06-28
Access to high cost medicines in Australia: ethical perspectives. (Pubmed Abstract) Authors Lu CY, Macneill P, Williams K, Day R Abbreviation Aust New Zealand Health Policy Volume 5 Publication Date 2008-05-19
Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007. (Pubmed Abstract) Authors Lu CY, Ross-Degnan D, Soumerai SB, Pearson SA Abbreviation BMC Health Serv Res Volume 8 Publication Date 2008-04-07
The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in Australia. (Pubmed Abstract) Authors Lu CY, Ritchie J, Williams K, Day R Abbreviation Aust New Zealand Health Policy Volume 4 Publication Date 2007-12-20
Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme? (Pubmed Abstract) Authors Lu CY, Williams KM, Day RO Abbreviation Intern Med J Volume 37 Issue 9 Publication Date 2007-06-02
The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines. (Pubmed Abstract) Authors Lu CY, Williams KM, Day RO Abbreviation Aust New Zealand Health Policy Volume 4 Publication Date 2007-03-01
Accessing health outcome data on high-cost medicines in Australia. (Pubmed Abstract) Authors Lu CY, Williams KM, Day RO Abbreviation Med. J. Aust. Volume 184 Issue 8 Publication Date 2006-04-17
Access to tumour necrosis factor inhibitors for rheumatoid arthritis treatment under the Australian Pharmaceutical Benefits Scheme: are we on target? (Pubmed Abstract) Authors Lu CY, Williams KM, Day RO Abbreviation Intern Med J Volume 36 Issue 1 Publication Date 2006-01-01
Recent developments in targeting access to high cost medicines in Australia. (Pubmed Abstract) Authors Lu CY, Ritchie J, Williams KM, Day RO Abbreviation Aust New Zealand Health Policy Volume 2 Publication Date 2005-11-23
Tailoring access to high cost, genetically targeted drugs. (Pubmed Abstract) Authors Hall WD, Ward R, Liauw WS, Lu CY, Brien JA Abbreviation Med. J. Aust. Volume 182 Issue 12 Publication Date 2005-06-20
Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible? (Pubmed Abstract) Authors Lu CY, Williams KM, March L, Bertouch JV, Day RO Abbreviation Med. J. Aust. Volume 181 Issue 8 Publication Date 2004-10-18
Access to high cost drugs in Australia. (Pubmed Abstract) Authors Lu CY, Williams K, Day R, March L, Sansom L, Bertouch J Abbreviation BMJ Volume 329 Issue 7463 Publication Date 2004-09-21